(1)
Moraes, R.; Ferreira, M.; Vaz, R.; Coelho, I.; Pinheiro, G.; Gonçalves, J.; França, M.; Almeida, I. Prevalence of Neuropsychiatric Adverse Effects in HIV Patients Treated With Dolutegravir. RPMI 2019, 26, 14-20.